These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1387164)

  • 1. Brainstem 5-hydroxytrytamine1A binding sites are not down-regulated by agonists which induce tolerance in the rat: myoclonus and other serotonergic behaviors.
    Murthy JN; Pranzatelli MR
    J Recept Res; 1992; 12(3):287-97. PubMed ID: 1387164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
    Pranzatelli MR; Pluchino RS
    Pharmacol Biochem Behav; 1991 Jun; 39(2):407-13. PubMed ID: 1835098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants.
    Martin KF; Phillips I; Hearson M; Prow MR; Heal DJ
    Br J Pharmacol; 1992 Sep; 107(1):15-21. PubMed ID: 1422568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
    Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
    Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action.
    Kennett GA; Marcou M; Dourish CT; Curzon G
    Eur J Pharmacol; 1987 Jun; 138(1):53-60. PubMed ID: 2442002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
    Smith LM; Peroutka SJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
    Hjorth S
    Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional significance of neonatal 5,7-dihydroxytryptamine lesions in the rat: response to selective 5-HT1A and 5-HT2,1C agonists.
    Pranzatelli MR; Dollison AM; Huang YY
    Brain Res Bull; 1990 Jun; 24(6):747-53. PubMed ID: 2142615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.
    Kennett GA; Dourish CT; Curzon G
    Eur J Pharmacol; 1987 Feb; 134(3):265-74. PubMed ID: 2883013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
    Yocca FD; Wright RN; Margraf RR; Eison AS
    Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.